<DOC>
	<DOCNO>NCT02651714</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled study conduct United States subject treatment-resistant pruritus diagnose atopic dermatitis .</brief_summary>
	<brief_title>Tradipitant Treatment-resistant Pruritus Associated With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Male nonpregnant , nonlactating female subject age 18 65 year ( inclusive ) ; Diagnosed atopic dermatitis Suffering chronic pruritus pruritus actively present Chronic pruritus due condition atopic dermatitis ( AD ) Participation previous tradipitant ( LY686017 VLY686 ) trial ; Anyone affiliate site sponsor and/or anyone may consent duress ; Any sound medical reason determine Investigator include condition may lead unfavorable riskbenefit study participation , may interfere study compliance may confound study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>